Palisade Selling General Administrative from 2010 to 2024

PALI Stock  USD 4.82  0.21  4.56%   
Palisade Bio's Selling General Administrative is increasing with slightly volatile movements from year to year. Selling General Administrative is estimated to finish at about 6.6 M this year. For the period between 2010 and 2024, Palisade Bio, Selling General Administrative quarterly trend regression had mean deviation of  1,449,712 and range of 7.6 M. View All Fundamentals
 
Selling General Administrative  
First Reported
2006-06-30
Previous Quarter
1.6 M
Current Value
1.5 M
Quarterly Volatility
587.7 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Palisade Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Palisade main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 K, Interest Expense of 14.2 K or Selling General Administrative of 6.6 M, as well as many exotic indicators such as Price To Sales Ratio of 17.64, Dividend Yield of 0.0 or PTB Ratio of 0.34. Palisade financial statements analysis is a perfect complement when working with Palisade Bio Valuation or Volatility modules.
  
This module can also supplement various Palisade Bio Technical models . Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.

Latest Palisade Bio's Selling General Administrative Growth Pattern

Below is the plot of the Selling General Administrative of Palisade Bio over the last few years. It is Palisade Bio's Selling General Administrative historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Palisade Bio's overall financial position and show how it may be relating to other accounts over time.
Selling General Administrative10 Years Trend
Slightly volatile
   Selling General Administrative   
       Timeline  

Palisade Selling General Administrative Regression Statistics

Arithmetic Mean6,294,923
Geometric Mean5,903,050
Coefficient Of Variation31.50
Mean Deviation1,449,712
Median6,202,000
Standard Deviation1,982,873
Sample Variance3.9T
Range7.6M
R-Value0.53
Mean Square Error3.1T
R-Squared0.28
Significance0.04
Slope233,443
Total Sum of Squares55T

Palisade Selling General Administrative History

20246.6 M
20236.2 M
20228.8 M
20219.3 M
20206.2 M
20197.3 M
20184.6 M

About Palisade Bio Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Palisade Bio income statement, its balance sheet, and the statement of cash flows. Palisade Bio investors use historical funamental indicators, such as Palisade Bio's Selling General Administrative, to determine how well the company is positioned to perform in the future. Although Palisade Bio investors may use each financial statement separately, they are all related. The changes in Palisade Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Palisade Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Palisade Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Palisade Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Selling General Administrative6.2 M6.6 M

Currently Active Assets on Macroaxis

When determining whether Palisade Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Palisade Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Palisade Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Palisade Bio Stock:
Check out the analysis of Palisade Bio Correlation against competitors.
For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Palisade Stock analysis

When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(23.46)
Return On Assets
(0.63)
Return On Equity
(1.13)
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.